Passage Bio, Inc. financial statements
Passage Bio, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 45.52M | 10-K |
| Cash and equivalents | USD 46.3M | 10-Q |
| Total debt | USD 24.01M | EODHD |
Passage Bio, Inc. financials on 6ix · Passage Bio, Inc. on 6ix